🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will examine the long-term safety of buntanetap in participants ...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2026-01-09
Trial ID
NCT07284784
Treatments Being Tested
This study evaluates the safety and pharmacological effects of 3 different ...
Status
Completed
Location
UCSD Alzheimer's Disease Research Center
Start Date
2017-03-02
Trial ID
NCT02925650
The purpose of this study is to measure efficacy and safety of three differ...
Status
Completed
Location
CCT Research - Gilbert Neurology Partners
Start Date
2023-04-01
Trial ID
NCT05686044
Treatments Being Tested
The purpose of this study is to measure safety and efficacy of buntanetap/p...
Status
Completed
Location
University of Alabama at Birmingham (UAB)- The Kirklin Clinic
Start Date
2022-08-03
Trial ID
NCT05357989
Treatments Being Tested
The goal of this clinical trial is to evaluate if phenserine can treat earl...
Status
Completed
Location
Stavanger University Hospital
Start Date
2025-02-01
Trial ID
NCT06774261
Treatments Being Tested
The goal of this clinical trial is to learn if buntanetap/Posiphen works to...
Status
Active Not Recruiting
Location
MD First Research
Start Date
2025-02-04
Trial ID
NCT06709014
Treatments Being Tested
This trial will determine the pharmacokinetics of Posiphen® in both plasma ...
Status
Terminated
Location
CEDRA Clinical Research, LLC
Start Date
2010-02
Trial ID
NCT01072812
Treatments Being Tested
This study will examine the long-term safety of buntanetap in participants ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-21
Trial ID
NCT07757204
Treatments Being Tested
Annovis is conducting a clinical study to investigate Posiphen in patients ...
Status
Completed
Location
New England Institute for Clinical Research
Start Date
2020-08-14
Trial ID
NCT04524351